SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

Alliqua, Inc. (ALQA)

ALQA RSS Feed
Add ALQA Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 10/20/2017 9:43:30 AM - Followers: 78 - Board type: Free - Posts Today: 1




Headquartered in New York, Alliqua, Inc., (OTCBB:ALQA) is a biomedical company focused on the development, manufacturing and marketing of its own proprietary products, utilizing its existing technology portfolio. It intends to pursue projects in the fields of active ingredient and transdermal drug delivery, as well as advanced wound care.

 

Alliqua's core transdermal delivery technology platform is designed to deliver drugs and other beneficial ingredients through the skin.  Transdermal delivery has multiple advantages over conventional oral and injection delivery including:


  • Avoidance of hepatic first pass metabolism causing less stress on the liver;
  • Non-invasive nature;
  • Improved patient compliance;
  • Discontinuation of administration by removal of the system;
  • Lower dosage;
  • No dependence on different metabolic rates of individuals; and
  • No interaction with the gastrointestinal system.

In addition, Alliqua's  patch technology can be utilized for the delivery of many drugs, including various proteins that have, until now, necessitated injections or intravenous infusions.

Alliqua intends to capitalize on its technology's other intrinsic benefits in various market verticals in the healthcare industry, including: wound healing, medical diagnostics and cosmeceuticals.


 

         


http://alliqua1.nextmp.net/about.html
http://www.aquamedinc.net/
http://googlerankingchecb03.unblog.fr/2012/08/13/gold-keyword-rank-checker-when-damp-emits-ions/
http://www.hepalifebiosystems.com/press-releases.php


 


 

Technology


Alliqua, through its wholly owned subsidiary AquaMed, develops, manufactures and markets electron-beam cross-linked sheet gels for use as transdermal delivery of medication, topical application of non-prescription drugs, wound/burn dressings with and without active ingredients, components in certain medical devices, treatments, cosmetics and other commercial products.

Hydrogels are gel-like or colloidal substances made of water and solids.  They can be created chemically (through a combination of ultra violet cross-linking and chemical interface), or by mixing polymer and water, and then exposing it to an electron beam creating a "sheet" of water. Alliqua believes that its hydrogels have a competitive advantage, in part due to the following product characteristics: painless adhesion to the human body, stability of form and composition, purity, reproducibility (manufacturing high quality product on a consistent basis), compatibility with active ingredients, and high water content.

Many of the products of Alliqua's competition feature physical characteristics which Alliqua believes are less desirable than its own hydrogels
 




Investor relations

Alliqua Inc.
850 3rd Avenue
Suite 1801
New York, NY 10022
646.218.1450

.

Products

Subsidiary Products
Alliqua Biomedical PHN Patch
  Hydress + Plus
  Hydress
Aquamed Technologies Contract Manufacturing Services
  Electrode Gel
  Sheet Hydrogels
HepaLife Biosystems HepaMate®

Alliqua is currently servicing the medical components marketplace through it Aquamed Technologies, Inc. subsidiary. It is also developing finished products for commercialization under its own brand names. The following table lists the various product in commercialization and development:

 

RECENT HEADLINES


Thursday, November 15, 2012

Wednesday, November 14, 2012

Tuesday, November 13, 2012

Wednesday, October 3, 2012

Wednesday, August 22, 2012

Thursday, August 16, 2012

Tuesday, August 14, 2012

Thursday, August 2, 2012

Tuesday, June 5, 2012

Thursday, May 24, 2012

CHARTS : 60 minutes - Daily - Weekly

 




 
SureTrader
Interactive Brokers Advertisement
ALQA
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PostSubject
#4748   Eruption Soon zino 10/20/17 09:43:29 AM
#4747   New Low floater...has big upside in todays bio-market zino 10/19/17 03:37:52 PM
#4746   Wait for the shorts to do their job bryce7517 10/07/17 04:52:47 AM
#4745   buying now would be dangerous, IMHO. They bryce7517 10/07/17 04:49:56 AM
#4744   buyers are back..... could see a nice move Maxgambit 10/06/17 10:38:39 AM
#4743   buyers are back..... could see a nice move Maxgambit 10/06/17 10:38:38 AM
#4742   Finally. We need to get that cloud bryce7517 10/06/17 05:36:15 AM
#4741   Alliqua BioMedical, Inc. Announces 1-for-10 Reverse Stock Split nbm16yankees 10/05/17 04:23:06 PM
#4740   Is it just me, but on the day bryce7517 09/29/17 05:30:38 AM
#4739   $ALQA volume was 461,534 Bunti 09/22/17 10:03:31 AM
#4738   I agree with you ABOUT. This bryce7517 09/22/17 06:12:39 AM
#4737   This is rocking. About to break HOD Barry Allen 09/21/17 03:25:56 PM
#4736   CELGENE CORPORATION Owns 18.8% Of Company zino 09/21/17 09:45:20 AM
#4735   Celgene Buying in ...I'm Buying zino 09/21/17 09:34:04 AM
#4734   this company has great products, but terrible management. bryce7517 09/16/17 09:07:29 AM
#4733   what a trap!:/ juancarlos 09/14/17 01:31:09 PM
#4732   So, here it is in writing. They bryce7517 09/14/17 05:53:43 AM
#4731   I am also anxious to hear about the bryce7517 09/13/17 07:27:47 PM
#4730   09-13-17 Shareholder meeting news? Did they release any Tyrant Tommy 09/13/17 11:20:08 AM
#4729   traders proffetti 09/10/17 03:31:30 PM
#4728   i would lean your way on this. This bryce7517 09/07/17 02:11:02 PM
#4727   So they do a 10-1 reverse split. By Tyrant Tommy 09/06/17 06:41:25 PM
#4726   i do not think zero, but, no reason bryce7517 09/06/17 04:22:21 PM
#4725   Losing %3 per day, at this rate zero Acen176 09/06/17 01:28:04 PM
#4724   Last 8K puts updates in writing of executives Acen176 09/02/17 02:09:49 PM
#4723   good, let's get this issue behind us. bryce7517 09/01/17 05:48:09 AM
#4722   September 13th is when the shareholder meeting will Tyrant Tommy 08/30/17 01:24:52 PM
#4721   CELG has a market value of 103B Kamal1234 08/29/17 06:35:04 AM
#4720   I cannot find the news. When bryce7517 08/29/17 06:11:01 AM
#4719   I found it sept 13 swiftearl 08/28/17 08:22:21 PM
#4718   When is that? Tia swiftearl 08/28/17 08:20:29 PM
#4717   i would wait until they clarify about the bryce7517 08/28/17 07:39:15 PM
#4716   Just bought at HOD lol I'm in though swiftearl 08/28/17 05:45:04 PM
#4715   * * $ALQA Video Chart 08-28-17 * * ClayTrader 08/28/17 05:12:39 PM
#4714   nice action ah! zetti 08/28/17 04:54:45 PM
#4713   https://seekingalpha.com/news/3292130-fda-clears-alliqua-biomedicals-silverseal- Learning2Invest 08/28/17 04:51:03 PM
#4712   Love it Awl416 08/28/17 04:48:41 PM
#4711   There is news, but no PR yet... nbm16yankees 08/28/17 04:43:16 PM
#4710   $$$ Tdash 08/28/17 04:37:16 PM
#4709   Thanks zetti 08/28/17 04:19:31 PM
#4708   Celgene has increased their position in ALQA twice Lone Wolf 08/28/17 04:13:37 PM
#4707   Really! But why up? Cant find any news! zetti 08/28/17 04:08:39 PM
#4706   Good day today VERITAS77 08/28/17 04:04:29 PM
#4705   Celgene? Lone Wolf 08/28/17 03:49:42 PM
#4704   took a position here at .38 LicharTin 08/28/17 12:43:00 PM
#4703   That was fun Awl416 08/28/17 10:15:55 AM
#4702   BOOM! doogdilinger 08/28/17 10:15:54 AM
#4701   A few months ago the company talked about bryce7517 08/22/17 12:19:48 PM
#4700   Maybe that's why there's a ceiling on the dwh 08/16/17 08:15:46 PM
#4699   Gotta breach $1.50. Looking great here!! $TOPS Lone Wolf 08/10/17 09:37:16 AM
PostSubject